Abingdon Health (LSE:ABDX) FCF Margin % : -50.66% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Abingdon Health's Free Cash Flow for the six months ended in Dec. 2023 was £-1.22 Mil. Abingdon Health's Revenue for the six months ended in Dec. 2023 was £2.41 Mil. Therefore, Abingdon Health's FCF Margin % for the quarter that ended in Dec. 2023 was -50.66%.

As of today, Abingdon Health's current FCF Yield % is -17.02%.

The historical rank and industry rank for Abingdon Health's FCF Margin % or its related term are showing as below:

LSE:ABDX' s FCF Margin % Range Over the Past 10 Years
Min: -299.79 Med: -44.09 Max: 18.69
Current: -44.39

During the past 6 years, the highest FCF Margin % of Abingdon Health was 18.69%. The lowest was -299.79%. And the median was -44.09%.

LSE:ABDX's FCF Margin % is ranked worse than
68.47% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs LSE:ABDX: -44.39

Abingdon Health FCF Margin % Historical Data

The historical data trend for Abingdon Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health FCF Margin % Chart

Abingdon Health Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

-44.09

8.31

-173.24

-299.79

18.69

Abingdon Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial					-291.90	-311.67	171.65	-39.23	-50.66

Competitive Comparison of Abingdon Health's FCF Margin %

For the Diagnostics & Research subindustry, Abingdon Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abingdon Health's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Abingdon Health's FCF Margin % falls into.

Abingdon Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Abingdon Health's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	0.756	/	4.045
	=	18.69 %

Abingdon Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.221	/	2.41
	=	-50.66 %

Abingdon Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Abingdon Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (LSE:ABDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines